Dentsply Sirona (XRAY) said Tuesday that it is evaluating "strategic alternatives" for its Wellspect Healthcare business.
The review process has no set timetable and there is no assurance it will result in a transaction, the company said.
The company's shares were up more than 2% in recent premarket activity Tuesday.
Price: 18.92, Change: +0.46, Percent Change: +2.5
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.